You are joining 1,200+ patients around the world who have participated in our clinical trials. Thank you!
IONIQ Sciences envisions a world where cancer is no longer feared – where it is readily treatable and no longer a financial burden. Lives and money can be saved when cancer is detected at its earliest, most-treatable stages.
We are developing a modern solution to be used at the point-of-care for early detection of multiple cancers thereby expanding the therapeutic window, significantly improving survivability, and reducing the cost of healthcare.
We will not be satisfied until the scourge of cancer has been eliminated and your participation in our clinical trials will directly help us modernize early-stage cancer detection.
Over the last 15 years we have worked with premier institutions around the world accumulating a substantial library of clinical evidence resulting in a Breakthrough Device Designation from the US FDA for our ProLung Test. From this foundation, we are transitioning from developing a single Lung Cancer Test to developing a Multi-Cancer Screen.